Incyte Corporation - Company & Market Research Reports

Incyte's is a biopharmaceutical company building a pipeline of small molecule drugs for serious unmet medical needs primarily in the area of oncology. Incyte's corporate headquarters are located in Wilmington, Delaware.


Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • 682 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • 682 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report - Product Thumbnail Image

Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report

  • Report
  • 200 Pages
From
Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023 - Product Thumbnail Image

Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023

  • Clinical Trials
  • 190 Pages
From
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 - Product Thumbnail Image

Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018

  • Report
  • 1000 Pages
From
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 - Product Thumbnail Image

Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018

  • Report
  • 1000 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
2018 Sickle Cell Disease Or Sickle Cell Anemia Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Sickle Cell Disease Or Sickle Cell Anemia Market - Product Thumbnail Image

2018 Sickle Cell Disease Or Sickle Cell Anemia Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Sickle Cell Disease Or Sickle Cell Anemia Market

  • Report
  • 70 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
Market Spotlight: Myelofibrosis - Product Thumbnail Image

Market Spotlight: Myelofibrosis

  • Report
  • 30 Pages
From
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 140 Pages
From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • 91 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018

  • Report
  • 63 Pages
From
Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015 - Product Thumbnail Image

Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015

  • Drug Pipelines
  • 1200 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
Skin Disease Treatment Technologies and Global Markets - Product Thumbnail Image

Skin Disease Treatment Technologies and Global Markets

  • Report
  • 128 Pages
From
Loading Indicator
adroll